Macquarie described Neuren Pharmaceuticals shares as a standout in the biotech industry and set a price target of $18.60 on ...

In morning trade, the ASX 200 uranium stock is up 2% to $4.57. This leaves it just short of its 52-week high of $4.63.

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor ...

Analysts from Morgan Stanley believe the humanoid robot market could be worth $5 trillion by 2035. Musk believes Tesla could ...

This ASX 300 stock is having a good session on Wednesday. Let's see why investors are bidding its shares higher ...

Dylan Evans from Catapult Wealth has provided his views on two popular ASX REITs, Goodman Group (ASX: GMG) and BWP Trust (ASX ...

Are Brickworks Ltd (ASX: BKW) or Reliance Worldwide Corporation Ltd (ASX: RWC) shares the better buy? Let's find ...

These 2 ASX growth shares could deliver big returns, in my opinion. Here’s why I’m excited about them right now.

Citi currently has a buy rating and $2.70 price target on its shares. Another ASX dividend stock that has been given a buy ...

The ASX dividend share is one of the leaders in the sector, in my opinion. It's expecting to pay a distribution per security ...

Aurizon Holdings has struck a new deal with materials giant BHP. Macquarie believes this is good news for Aurizon shares.